Search results
Moderna just got FDA approval for its RSV vaccine — only its second product on the market
Quartz· 1 day agoThe Food and Drug Administration on Friday approved Moderna’s mRNA-based respiratory syncytial virus...
Why Moderna Stock Is Sinking This Week | The Motley Fool
The Motley Fool· 2 days agoShares of Moderna (MRNA 2.41%) were sinking 9% lower this week as of Thursday's market close,...
Moderna’s RSV Shot Wins FDA Approval for Use in Older Adults
Bloomberg· 1 day agoModerna Inc. gained US approval for its RSV vaccine in older adults, giving the biotech company a...
Moderna secures a second FDA vaccine approval as Spikevax sales plummet
Fast Company Magazine· 22 hours agoModerna announced on Friday that the U.S. Food and Drug Administration (FDA) has approved its...
Moderna wins second product approval with RSV vaccine
Market Watch· 1 day agoModerna Inc.’s respiratory syncytial virus vaccine for older adults received U.S. regulatory...
Moderna Could Pull Back Even More as Traders Nail Down Profits
TheStreet.com· 4 days agoModerna Could Pull Back Even More as Traders Nail Down Profits
The Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why.
Barrons.com· 3 days agoWhat began Tuesday as a puzzling dip in shares of the biotech Moderna accelerated into a larger...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
AOL· 1 day agoThe U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new ...
US FDA approves Moderna’s RSV vaccine, its second marketed product
WSAU Wausau· 1 day agoBy Patrick Wingrove (Reuters) - The U.S. Food and Drug Administration has approved Moderna's...
Analyst Report: Moderna, Inc.
Morningstar Research via Yahoo Finance· 24 hours agoModerna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with ...